CABA
Cabaletta Bio, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -9.1% ·
aandelenstroom -27.2% ·
netto nieuwe posities -10.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +17 | 94.18M | $292.87M | +24 | −6 |
| Q1 2026 | 49 | +1 | 47.68M | $128.08M | +7 | −6 |
| Q4 2025 | 47 | +1 | 39.89M | $87.37M | +1 | — |
| Q3 2025 | 15 | -1 | 24.60M | $57.56M | — | −1 |
| Q2 2025 | 13 | 0 | 19.37M | $29.44M | — | — |
| Q1 2025 | 10 | -1 | 6.81M | $9.44M | +2 | −3 |
| Q4 2024 | 11 | 0 | 9.36M | $21.24M | +1 | −1 |
| Q3 2024 | 10 | +2 | 7.88M | $37.20M | +2 | — |
| Q2 2024 | 8 | — | 6.49M | $48.56M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 3.63M | 0.0% | $5.03M | 0.0% | Held | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 1.14M | +2.8% | $1.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 1.14M | +2.8% | $1.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 938.72K | +0.1% | $1.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 489.32K | -6.6% | $678,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 489.32K | -6.6% | $678,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 321.41K | -57.2% | $445,154 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Millennium Management ✦ | 168.90K | -67.0% | $233,925 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 73.96K | Nieuw | $102,429 | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 73.96K | Nieuw | $102,429 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 73.96K | Nieuw | $102,429 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 73.96K | Nieuw | $102,429 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 73.96K | Nieuw | $102,429 | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 33.46K | -82.7% | $46,509 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Marshall Wace ✦ | 33.46K | -82.7% | $46,509 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 10.90K | -95.3% | $15,097 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 350 | Nieuw | $485 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $102,429 | 0.0% |
| AQR Capital Management | $102,429 | 0.0% |
| AQR Capital Management | $102,429 | 0.0% |
| AQR Capital Management | $102,429 | 0.0% |
| AQR Capital Management | $102,429 | 0.0% |
| Citadel Advisors | $485 | 0.0% |
Verlaten
| Point72 Asset Management | $2.87M | was 0.0% |
| Wellington Management | $408,956 | was 0.0% |
| D. E. Shaw & Co. | $37,691 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 107 houders, 84.67M aandelen, $194.86M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.